ON THE BIOCHEMICAL-MODE OF ACTION OF LEVAMISOLE - AN UPDATE

被引：34

作者：

VANWAUWE, J

JANSSEN, PAJ

机构：

[1] Janssen Research Foundation

来源：

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1991年 / 13卷 / 01期

关键词：

D O I：

10.1016/0192-0561(91)90019-4

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：3 / 9

页数：7

共 46 条

[1] LEVAMISOLE AND IMMUNOTHERAPY - SOME THEORETIC AND PRACTICAL CONSIDERATIONS AND THEIR RELEVANCE TO HUMAN-DISEASE [J].

AMERY, WK ;

GOUGH, DA .

ONCOLOGY, 1981, 38 (03) :168-181

[2] ADJUVANT TREATMENT WITH LEVAMISOLE IN CANCER - REVIEW OF EXPERIMENTAL AND CLINICAL DATA [J].

AMERY, WK ;

SPREAFICO, F ;

ROJAS, AF ;

DENISSEN, E ;

CHIRIGOS, MA .

CANCER TREATMENT REVIEWS, 1977, 4 (03) :167-194

[3] THE DOSAGE REGIMEN OF LEVAMISOLE IN CANCER - IS IT RELATED TO EFFICACY AND SAFETY [J].

AMERY, WK ;

BUTTERWORTH, BS .

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1983, 5 (01) :1-9

[4]

AMERY WK, 1982, CURRENT CONCEPTS HUM, P585

[5]

ANDERSON R, 1976, J IMMUNOL, V117, P428

[6] INHIBITION OF INTERFERON OR SOLUBLE IMMUNE-RESPONSE SUPPRESSOR (SIRS) MEDIATED SUPPRESSION BY LEVAMISOLE [J].

AUNE, TM ;

PIERCE, CW .

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1983, 5 (01) :91-98

[7]

AUNE TM, 1987, CRIT REV IMMUNOL, V7, P93

[8] ISOLATION OF A CDNA CLONE CODING FOR A POSSIBLE NEURAL NICOTINIC ACETYLCHOLINE-RECEPTOR ALPHA-SUBUNIT [J].

BOULTER, J ;

EVANS, K ;

GOLDMAN, D ;

MARTIN, G ;

TRECO, D ;

HEINEMANN, S ;

PATRICK, J .

NATURE, 1986, 319 (6052) :368-374

[9] DL-2-OXO-3-(2-MERCAPTOETHYL)-5-PHENYLIMIDAZOLIDINE - SULFHYDRYL METABOLITE OF LEVAMISOLE THAT INTERACTS WITH MICROTUBULES [J].

DEBRABANDER, M ;

AERTS, F ;

GEUENS, G ;

VANGINCKEL, R ;

VANDEVEIRE, R ;

VANBELLE, H .

CHEMICO-BIOLOGICAL INTERACTIONS, 1978, 23 (01) :45-63

[10]

DEBRABANDER M, 1979, INT J IMMUNOPHARMACO, V1, P8

← 1 2 3 4 5 →